Skip to main content

Antibody-negative neuromyelitis optica with heavy B-cell infiltration

Buy Article:

$51.00 plus tax (Refund Policy)

Blackburn D, Robin Highley J, Wharton S, Romanowski C, Bowen J, Sharrack B. Antibody-negative neuromyelitis optica with heavy B-cell infiltration. APMIS 2009; 117: 768–72.

There are several distinct clinical phenotypes of inflammatory demyelinating diseases of the central nervous system. In classical multiple sclerosis (MS) there are varied pathological patterns, possibly with differences in pathogenesis. Neuromyelitis optica (NMO) is often associated with a specific antibody, suggesting a distinct pathogenesis. We report a case of a young Caucasian male who presented with right hemiparesis secondary to a left fronto-parietal inflammatory brain lesion, which improved over years leaving minimal deficit. Seventeen years later he re-presented with a progressive tetraparesis secondary to cervical myelitis that did not respond to treatment. The NMO antibody was not detected and neuropathological examination was unusual with evidence of a persistent B-cell inflammatory response in the cord. Although having some of the clinical features of NMO, this case presented novel clinico-pathological features that do not easily fit into current MS subtypes.
No References
No Citations
No Supplementary Data
No Data/Media
No Metrics

Keywords: B lymphocytes; Neuromyelitis optica

Document Type: Research Article

Affiliations: 1: Department of Neurology, Royal Hallamshire Hospital, University of Sheffield, Sheffield; 2: Department of Neuroscience, Academic Unit of Pathology, University of Sheffield Medical School, Sheffield

Publication date: 2009-10-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more